AISAP has developed an FDA-cleared cardiac AI platform that enables non-cardiologists to diagnose heart disease using handheld ultrasound devices. Deployed in U.S. hospitals and Ghana clinics, the technology may redefine access to cardiovascular diagnostics worldwide.